These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31797167)

  • 1. Correction to: Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis.
    Pohjankoski H; Kautiainen H; Lauri JV; Puolakka K; Rantalaiho V
    Clin Rheumatol; 2020 Jan; 39(1):299. PubMed ID: 31797167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
    Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y;
    Clin Trials; 2018 Jun; 15(3):268-277. PubMed ID: 29542334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction to: Differing X-ray patterns in seronegative and seropositive rheumatoid arthritis.
    Gadeholt O; Hausotter K; Eberle H; Klink T; Pfeil A
    Clin Rheumatol; 2019 Sep; 38(9):2647. PubMed ID: 31346842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to: Prevalence of colorectal cancer in acute uncomplicated diverticulitis and the role of the interval colonoscopy.
    Soh NYT; Chia DKA; Teo NZ; Ong CJM; Wijaya R
    Int J Colorectal Dis; 2018 Aug; 33(8):1145. PubMed ID: 29808306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction to: Conservative Sinusectomy vs. excision and primary off-midline closure for pilonidal disease: a randomized controlled trial.
    Popeskou SG; Pravini B; Panteleimonitis S; Ferrario di Tor Vajana A; Vanoni A; Schmalzbauer M; Posabella A; Christoforidis D
    Int J Colorectal Dis; 2020 Jul; 35(7):1201. PubMed ID: 32458393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis.
    Hügle B; Horneff G
    Expert Opin Pharmacother; 2016; 17(5):703-14. PubMed ID: 26678914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit.
    Di Napoli A; Remotti D; Agostinelli C; Ambrosio MR; Ascani S; Carbone A; Facchetti F; Lazzi S; Leoncini L; Lucioni M; Novero D; Pileri S; Ponzoni M; Sabattini E; Tripodo C; Zamò A; Paulli M; Ruco L
    Virchows Arch; 2019 Dec; 475(6):799. PubMed ID: 31664506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
    Kimura Y; Grevich S; Beukelman T; Morgan E; Nigrovic PA; Mieszkalski K; Graham TB; Ibarra M; Ilowite N; Klein-Gitelman M; Onel K; Prahalad S; Punaro M; Ringold S; Toib D; Van Mater H; Weiss JE; Weiss PF; Schanberg LE;
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):23. PubMed ID: 28399931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to: Systematic reporting to improve the emergency medical response to major incidents: a pilot study.
    Hardy S; Fattah S; Wisborg T; Raatiniemi L; Staff T; Rehn M
    BMC Emerg Med; 2018 Feb; 18(1):6. PubMed ID: 29426282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
    Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile Idiopathic Arthritis.
    Barut K; Adrovic A; Şahin S; Kasapçopur Ö
    Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
    Shepherd J; Cooper K; Harris P; Picot J; Rose M
    Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.
    Nalbanti P; Kanakoudi-Tsakalidou F; Trachana M; Pratsidou-Gertsi P; Farmaki E; Bamidis P; Papachristou F
    Rheumatol Int; 2018 Jul; 38(7):1241-1250. PubMed ID: 29845429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis.
    Zajc Avramovič M; Dolžan V; Toplak N; Accetto M; Lusa L; Avčin T
    J Rheumatol; 2017 Aug; 44(8):1216-1223. PubMed ID: 28572465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function in children with juvenile idiopathic arthritis and effects of methotrexate therapy.
    Schmeling H; Stephan V; Burdach S; Horneff G
    Z Rheumatol; 2002 Apr; 61(2):168-72. PubMed ID: 12056294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids in juvenile idiopathic arthritis.
    Malattia C; Martini A
    Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canakinumab for the treatment of active systemic juvenile idiopathic arthritis.
    Orrock JE; Ilowite NT
    Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1015-24. PubMed ID: 27367267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the use of methotrexate in juvenile idiopathic arthritis.
    Niehues T; Lankisch P
    Paediatr Drugs; 2006; 8(6):347-56. PubMed ID: 17154642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction to: Health status of Polish children and adolescents after cancer treatment.
    Krawczuk-Rybak M; Panasiuk A; Stachowicz-Stencel T; Zubowska M; Skalska-Sadowska J; Sęga-Pondel D; Czajńska-Deptuła A; Sławińska D; Badowska W; Kamieńska E; Pobudejska-Pieniążek A; Wieczorek M
    Eur J Pediatr; 2018 Mar; 177(3):449. PubMed ID: 29374295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting.
    Brunelli JB; Schmidt AR; Sallum AME; Goldenstein-Schainberg C; Bonfá E; Silva CA; Aikawa NE
    Mod Rheumatol; 2018 Mar; 28(2):264-270. PubMed ID: 28949278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.